What separates the best companies?

Most online weight-loss programs can ship medication. The differences show up in everything around the prescription: how rigorous the medical intake is, whether a licensed clinician genuinely reviews your case, how honest the advertised price is, and whether anyone answers when side effects appear in week three.

Demand explains why the field is crowded — CDC/NCHS data puts adult obesity at 40.3% in the U.S. — but crowded markets reward marketing, not necessarily care quality. That gap is what a structured comparison closes.

The five criteria we weigh

• Medication access: Which treatments the company can prescribe — semaglutide, tirzepatide, oral options — and whether it offers brand-name products, compounded versions, or both, disclosed plainly.
• Clinician oversight: A real medical review at intake, screening consistent with the FDA's eligibility criteria (BMI 30+, or 27+ with a weight-related condition), and follow-up that continues past the first charge.
• Pricing transparency: The advertised number versus the real monthly total — visits, shipping, membership fees, and what happens to price at higher doses.
• Support quality: Whether you can message a clinician, how refills are timed, and what the side-effect escalation path looks like.
• Honest claims: Companies that cite trial averages responsibly outrank those promising specific results — no trial guarantees an individual outcome.

What treatments do these companies offer?

The ranked companies cluster around three offerings: GLP-1 injections — semaglutide (Wegovy, FDA-approved 2021) and tirzepatide (Zepbound, FDA-approved 2023) — oral prescription medications from NIDDK's approved list, and coaching or lifestyle programs bundled with or without medication.

The trial benchmarks for the injectables: an average 14.9% body-weight reduction at 68 weeks for semaglutide 2.4 mg in STEP 1, and 15.0% to 20.9% at 72 weeks across tirzepatide doses in SURMOUNT-1, both with lifestyle intervention included. Companies offering those medications are working from the same evidence — what differs is the care wrapped around it.

Red flags that drop a company down our list

• No real medical review — an intake you can complete in ninety seconds is not screening, it is a checkout flow.
• Hidden pharmacy sourcing — especially for compounded medication, where the filling pharmacy and contents should be disclosed before payment.
• Guaranteed-results language — anyone promising a number is overselling a medication whose trials report averages and ranges.
• Teaser pricing — a low first month that triples at maintenance doses, disclosed only after signup.
• No exit path — subscriptions that keep billing when treatment pauses, or cancellation buried behind support tickets.

How should you make the final choice?

Shortlist two or three companies from the chart that match your treatment preference — injections, pills, or coaching. Read their full reviews. Then confirm three numbers and one name before any online visit: the true monthly cost at your likely dose, the refill timing, the cancellation terms, and the pharmacy that fills your prescription.

Finally, remember what no company controls: eligibility and fit are medical judgments. NIDDK's guidance applies everywhere — medication works best alongside lifestyle change, never during pregnancy, and with a 12-week checkpoint to confirm it is working for you.